IA
JBIO

IFP Advisors’s Jade Biosciences JBIO Stock Holding History

IFP Advisors’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$133 Buy
+6
New +$125 ﹤0.01% 4922

Other funds holding JBIO

DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM
OCWP
Owl Creek Wealth Partners Denver, Colorado $342M AUM
HFS
Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return

IFP Advisors's JBIO Position: Q2 2026 in Review

IFP Advisors opened a new position in Jade Biosciences (JBIO) in Q2 2026: 6 shares worth $133. The stake represents ﹤0.01% of the portfolio and ranks #4922 among its holdings.

10 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • IFP Advisors held 6 shares of Jade Biosciences worth $133 as of Q2 2026.
  • Jade Biosciences was a new IFP Advisors position in Q2 2026.
  • Jade Biosciences made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4922 holding.
  • 10 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.